IMSS begins plasma treatment of COVID-19 patients
In this first phase of the protocol, the institution considers four central blood banks, including the one in Guadalajara
The Mexican Social Security Institute ( IMSS ) began a protocol for the treatment of patients with COVID -19 who suffer from a severe respiratory infection using convalescent plasma .
Through a statement, the IMSS specialist, Jaime David Macedo Reynada, explained that this protocol aims to collect plasma from patients who have recovered from the virus , because this blood component contains a significant load of antibodies.
Plasma is an alternative treatment for seriously ill patients, and it seeks to reduce mortality and the development of complications in these patients.
So far, plasma has been applied to seven patients with COVID -19 and the impact of this treatment on each of them is evaluated, said the doctor attached to the Central Blood Bank of the National Medical Center La Raza.
In this first phase of the protocol, he noted, four of the 12 Central Blood Banks that the IMSS has in the country have been considered: Monterrey, Guadalajara, and the national medical centers of La Raza and Siglo XXI.
The specialist explained that, because the authorization of Cofepris indicates that the component must be traced, record the data of the person who received the plasma and the result in their laboratory variables, at this time the plasma can only be administered in patients treated by Social Security.
For his part, the specialist from the laboratory of the Central Blood Bank La Raza, Oscar Zamudio Chávez, stressed that the safety of patients recovered from COVID-19 is guaranteed during the plasma collection process, as well as the fact that this blood component be safe for the beneficiaries who will receive it.
The protocol was registered on April 5, 2020 and authorized 10 days later by the IMSS Research Ethics, Research and Biosafety Committees.
Later, on April 22, the Federal Commission for the Protection of Health Risks (Cofepris) issued the opinion authorizing Social Security the clinical use of plasma from convalescent patients.
Google translation from Informador.